The only way to drive innovation and improve the efficiency of the sector is to create alliances and be collaborative; to be able to do more together than separately with patient-centered objectives. In this episode, we discuss the challenges and innovations that are transforming the landscape of drug development and clinical trials, and how we can grow in a market with so many players. Carlos Orantes, CEO of Alconza Clinical Research, shares his insights from over 30 years of experience in the industry, and dives into the importance of collaboration and teamwork to address all the industry c ..read more

Our latest guest is Sandy Smith, Senior VP of Clinical Solutions and Strategic Partnerships at WCG, a company that connects sponsors, CROs, sites, and participants to deliver efficient, safe and impactful clinical research. In this conversation, Sandy shares insights into her background as an advanced practice nurse and how she landed 3 years ago at WCG where she leads Clinical Solutions and Strategic Partnership to solve some of the biggest challenges in research. In this talk, Sandy will touch on her role connecting diverse stakeholders (sites, sponsors, CROs), while advocating for the pati ..read more

Accreditation and standardization are the keys to driving positive change in the clinical research industry, leaving a lasting legacy and making strides toward global collaboration. Today we’re joined by Jacqueline Johnson North, CEO and Co-Founder of GCSA. The Global Clinical Site Assessment Standard enables clinical research sites, CROs, and sponsors to work synergistically, while fostering a truly patient-centric system. We discuss the development of a certification standard for clinical research sites, the 7-module approach of their assessment, and the impact on the industry. Join as we ..read more

The success of any piece of software or solution = the quality of the solution x the buy-in and adoption of that solution. In today’s episode, our guest Dave Hine Senior Director of Sales Engineering at Greenphire, shares his unique journey from aerospace engineering to the clinical trial industry. The conversation highlights the importance of patient-centricity, explores Greenphire's innovative solutions, and delves into the challenges of patient enrollment. Dave shares insights on industry trends, has a clear vision for the future of clinical trials, and offers valuable advice for those ent ..read more

A unified system that enhances patient care, improves outcomes, and advances research to ensure the right patients receive the right therapies… That’s the goal. Our latest guest, Melisa Tucker, is a healthcare industry expert with a significant background in healthcare innovation and data utilization. She is currently serving as Head of Research Evidence Generation Program at Verily. Melisa discusses her journey in the clinical research landscape, emphasizing the importance of working with great people and staying curious to seize opportunities for personal and professional growth. The episo ..read more

The realm of clinical research holds boundless opportunities. Our latest guest, Julia Sundari, Senior Director of Clinical Design and Analytics at IQVIA, joins us with 30 intentional and passionate years in the industry, all beginning with participation in a research trial for NASA. In this episode we dive deep into innovative approaches such as risk-based monitoring, remote monitoring, and systems interoperability. She shares her experiences leading a global team of women, and sheds light on the importance of user-centered design and creating a seamless experience for both sites and subjects ..read more

Building better protocols — As we think about DCTs, site capabilities, diversity, equity & inclusion, and going global in research, it comes down to how protocol is designed and then ultimately, how regulatory agencies are going to view and deliver on these promises. Our latest guest Douglas Reichgott, Executive Director of Clinical Research at Beth Israel Deaconess Medical Center, shares his insights on the industry, reflecting on the changes he’s witnessed over the past 25 years and sharing his desires for the future in clinical research. Join us as we discuss; Benefits and challenges ..read more

The ultimate goal in the Clinical Research space is to make trials more accessible to the broader population. Inevitably, the industry has been struggling with enrollment and recruitment. In this episode, our guest Darcy Forman, Chief Delivery Officer at Science 37, shares insight into the implications of increasing clinical research accessibility, from increasing awareness among the general population to testing medications within the populations that will ultimately benefit from the treatments. Join us as we discuss: Pros and cons of transitioning from the pharmaceutical industry to the t ..read more

Clinical research is moving faster than ever. With developments in technology, distributed trials and accelerated research opportunities, the way we treat patients is adapting. According to Lauren Chang, VP of Strategic Growth at Clinical Research Fastrack, working in the evolving, accelerated world of clinical research takes a particular skillset — something she’s dedicated herself to helping cultivate in her current role. Join us as we discuss: The value of tech skills in any clinical practice Developing professional relationships and seeking mentorship Hard and soft skills necessary for ..read more

The focus on diversity, equity and inclusion (DEI) is gaining momentum across pharma and clinical trial environments. But, often, initiatives are difficult to enact within existing industry infrastructures. To truly embrace DEI in clinical trials, clinical trials must enter community clinics — many of which are not quite ready to enter the trials space. While the challenge is no small feat, our latest guest Jennifer Kim, Assistant Professor at Tufts University School of Dental Medicine is out to change the world of pharma and clinical trials by increasing access and diversity. According to he ..read more